PHARMAGREEN BIOTECH INC. Retained Earnings
PHARMAGREEN BIOTECH INC. had Retained Earnings of -$12.97 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-08-14
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$12.97M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$12.80M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$12.61M.
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$12.57M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-06-30 | -$12.97M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$12.80M 10-Q · filed 2023-05-19 |
| 2022-12-31 | -$12.61M 10-Q · filed 2023-02-14 |
| 2022-09-30 | -$12.57M 10-Q · filed 2023-08-14 |
| 2022-06-30 | -$12.46M 10-Q · filed 2022-08-17 |
| 2022-03-31 | -$12.72M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$11.68M 10-Q · filed 2022-02-22 |
| 2021-09-30 | -$11.70M 10-K · filed 2023-01-17 |
| 2021-06-30 | -$10.87M 10-Q · filed 2021-08-18 |
| 2021-03-31 | -$10.73M 10-Q · filed 2021-05-24 |
| 2020-09-30 | -$7.17M 10-K · filed 2021-12-29 |
| 2020-06-30 | -$6.30M 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$4.94M 10-Q · filed 2020-05-19 |
| 2019-12-31 | -$4.94M 10-Q · filed 2020-02-18 |
| 2019-09-30 | -$4.73M 10-K · filed 2021-01-08 |
| 2019-06-30 | -$4.51M 10-Q · filed 2019-08-19 |
| 2018-09-30 | -$3.96M 10-K · filed 2019-12-30 |